SO
STRS Ohio Portfolio holdings
AUM
$26.8B
1-Year Return
24.25%
This Quarter Return
+12.58%
1 Year Return
+24.25%
3 Year Return
+105.97%
5 Year Return
+185.64%
10 Year Return
+428.63%
AUM
$24B
AUM Growth
+$1.56B
(+6.9%)
Cap. Flow
-$962M
Cap. Flow
% of AUM
-4%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
2,061
New
128
Increased
454
Reduced
915
Closed
153
Top Buys
| 1 |
Broadcom
AVGO
|
+$43.2M |
| 2 |
VICI Properties
VICI
|
+$35.3M |
| 3 |
Elevance Health
ELV
|
+$27.8M |
| 4 |
Kite Realty
KRG
|
+$26.1M |
| 5 |
CrowdStrike
CRWD
|
+$23.8M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$55.4M |
| 2 |
Apple
AAPL
|
+$51M |
| 3 |
Synopsys
SNPS
|
+$45M |
| 4 |
Netflix
NFLX
|
+$44.8M |
| 5 |
Markel Group
MKL
|
+$35.4M |
Sector Composition
| 1 | Technology | 26.87% |
| 2 | Financials | 12.81% |
| 3 | Healthcare | 12.06% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Enanta Pharmaceuticals
ENTA
$191M
| $175K | ﹤0.01% |
18,700
+3,200
| +21% | +$29.9K |
|
1602
Liberty Latin America Class C
LILAK
$1.55B
| $175K | ﹤0.01% |
23,900
-63,300
| -73% | -$463K |
|
|
UCB
1603
United Community Banks, Inc.
UCB
$3.96B
| $175K | ﹤0.01% |
6,000
+900
| +18% | +$26.3K |
|
1604
Worthington Steel
WS
$1.58B
| $174K | ﹤0.01% |
+6,200
| New | +$174K |
|
1605
Gold Fields
GFI
$33.4B
| $173K | ﹤0.01% |
12,000
| – | – |
|
1606
Dycom Industries
DY
$7.54B
| $172K | ﹤0.01% |
1,500
+500
| +50% | +$57.3K |
|
1607
Ocular Therapeutix
OCUL
$2.23B
| $170K | ﹤0.01% |
38,200
| – | – |
|
1608
Omega Flex
OFLX
$336M
| $169K | ﹤0.01% |
2,400
| – | – |
|
1609
Integer Holdings
ITGR
$3.6B
| $168K | ﹤0.01% |
1,700
+600
| +55% | +$59.3K |
|
1610
Kadant
KAI
$3.73B
| $168K | ﹤0.01% |
600
+400
| +200% | +$112K |
|
|
ADAM
1611
Adamas Trust, Inc. Common Stock
ADAM
$651M
| $167K | ﹤0.01% |
19,625
| – | – |
|
1612
Walker & Dunlop
WD
$2.92B
| $166K | ﹤0.01% |
1,500
+800
| +114% | +$88.5K |
|
1613
M/I Homes
MHO
$3.97B
| $165K | ﹤0.01% |
1,200
+900
| +300% | +$124K |
|
1614
REV Group
REVG
$3.1B
| $165K | ﹤0.01% |
9,100
| – | – |
|
1615
American Well
AMWL
$109M
| $164K | ﹤0.01% |
5,510
| – | – |
|
1616
Belden
BDC
$5.12B
| $162K | ﹤0.01% |
2,100
-3,700
| -64% | -$285K |
|
1617
NorthWestern Energy
NWE
$3.45B
| $162K | ﹤0.01% |
3,200
-800
| -20% | -$40.5K |
|
1618
Resideo Technologies
REZI
$5.4B
| $161K | ﹤0.01% |
8,600
-9,900
| -54% | -$185K |
|
|
KREF
1619
KKR Real Estate Finance Trust
KREF
$645M
| $160K | ﹤0.01% |
12,100
| – | – |
|
1620
ACI Worldwide
ACIW
$5.19B
| $159K | ﹤0.01% |
5,200
+3,500
| +206% | +$107K |
|
1621
Cogent Communications
CCOI
$1.78B
| $159K | ﹤0.01% |
2,100
+300
| +17% | +$22.7K |
|
1622
Methode Electronics
MEI
$284M
| $159K | ﹤0.01% |
7,000
| – | – |
|
1623
Glaukos
GKOS
$5.08B
| $158K | ﹤0.01% |
2,000
-1,500
| -43% | -$119K |
|
1624
Arcus Biosciences
RCUS
$1.2B
| $158K | ﹤0.01% |
8,300
+5,900
| +246% | +$112K |
|
|
SAGE
1625
DELISTED
Sage Therapeutics
SAGE
| $158K | ﹤0.01% |
7,300
| – | – |
|